FBRX יחס מהיר Forte Biosciences, Inc.

The asset value of Forte Biosciences, Inc. (FBRX) tracked on this chart is currently at 9.51. This biotech business develops treatments for skin inflammation, and since the progress of clinical trials is independent of economic fluctuations, it ensures crisis resilience. Steady interest in new drugs transforms the company into a defensive asset, while the development of unique molecules will provide it with exceptional pricing power in the future.

Forte Biosciences, Inc. (FBRX) delegates production and clinical trials to external contractors, minimizing costs associated with internal inventory. This model ensures that the calculation of quick liquidity—via the sum of cash and accounts receivable—is maximally representative for assessing solvency. This metric determines the company's ability to instantaneously settle short-term debts without liquidating assets. The history of quick liquidity changes helps track the rate of capital expenditure on drug development.